No therapy has been proved to be effective for patients with severe chloroquine poisoning, which is usually fatal. In a retrospective study of 51 cases, we found that ingestion of more than 5 g of chloroquine was an accurate predictor of a fatal outcome, and therefore chose this dose as the criterion for severe chloroquine poisoning. We selected as a control group 11 consecutive patients who had ingested more than 5 g of chloroquine between July 1983 and December 1985. We then undertook a prospective study to determine whether a better outcome could be obtained with immediate mechanical ventilation and the administration of diazepam and epinephrine. Eleven consecutive patients who ingested more than 5 g of chloroquine in 1986 received this combination therapy. Ten of these patients survived, whereas only one control had survived (P = 0.0003). There was no significant difference between the combination-therapy and control groups in age (29 +/- 3 vs. 27 +/- 2 years), amount of chloroquine ingested (7.5 +/- 0.5 vs. 8.5 +/- 0.8 g), systolic arterial pressure (74 +/- 2 vs. 74 +/- 3 mm Hg), or QRS duration (0.14 +/- 0.01 vs. 0.14 +/- 0.01 second). In our combination-therapy group, blood chloroquine levels ranged from 40 to 80 mumol per liter, whereas a literature search showed that no patient in whom blood levels were more than 25 mumol per liter had survived. These preliminary data suggest that combining early mechanical ventilation with the administration of diazepam and epinephrine may be effective in the treatment of severe chloroquine poisoning.
Source Information
Service de Reanimation Medicale, Hopital de Bicetre, Universite Paris-XI, Le Kremlin-Bicetre, France.
This article has been cited by other articles:
Rodriguez-Menchaca, A. A., Navarro-Polanco, R. A., Ferrer-Villada, T., Rupp, J., Sachse, F. B., Tristani-Firouzi, M., Sanchez-Chapula, J. A.
(2008). The molecular basis of chloroquine block of the inward rectifier Kir2.1 channel. Proc. Natl. Acad. Sci. USA
105: 1364-1368
[Abstract][Full Text]
Winstanley, P., Ward, S., Snow, R., Breckenridge, A.
(2004). Therapy of Falciparum Malaria in Sub-Saharan Africa: from Molecule to Policy. Clin. Microbiol. Rev.
17: 612-637
[Abstract][Full Text]
Sánchez-Chapula, J. A., Salinas-Stefanon, E., Torres-Jácome, J., Benavides-Haro, D. E., Navarro-Polanco, R. A.
(2001). Blockade of Currents by the Antimalarial Drug Chloroquine in Feline Ventricular Myocytes. J. Pharmacol. Exp. Ther.
297: 437-445
[Abstract][Full Text]
Good, J. L., Chehrenama, M., Mayer, R. F., Koski, C. L.
(1998). Pulse cyclophosphamide therapy in chronic inflammatory demyelinating polyneuropathy. Neurology
51: 1735-1738
[Abstract][Full Text]
Apfel, S. C., Kessler, J. A., Adornato, B. T., Litchy, W. J., Sanders, C., Rask, C. A., The NGF Study Group*,
(1998). Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. Neurology
51: 695-702
[Abstract][Full Text]
Mirabella, M., Galluzzi, G., Manfredi, G., Bertini, E., Ricci, E., De Leo, R., Tonali, P., Servidei, S.
(1998). Giant dystrophin deletion associated with congenital cataract and mild muscular dystrophy. Neurology
51: 592-595
[Abstract][Full Text]
Kissel, J. T., Elble, R. J.
(1998). Stiff-person syndrome: Stiff opposition to a simple explanation. Neurology
51: 11-14
[Full Text]
Floeter, M. K., Valls-Sole, J., Toro, C., Jacobowitz, D., Hallett, M.
(1998). Physiologic studies of spinal inhibitory circuits in patients with stiff-person syndrome. Neurology
51: 85-93
[Abstract][Full Text]
Schmierer, K., Valdueza, J. M., Bender, A., DeCamilli, P., David, C., Solimena, M., Zschenderlein, R.
(1998). Atypical stiff-person syndrome with spinal MRI findings, amphiphysin autoantibodies, and immunosuppression. Neurology
51: 250-252
[Abstract][Full Text]
Sudo, K., Tashiro, K.
(1998). Cerebral white matter lesions associated with vitamin B12 deficiency. Neurology
51: 325-325
[Full Text]
Stojsavljevic, N., Levic, Z., Drulovic, J.
(1998). Cerebral white matter lesions associated with vitamin B12 deficiency. Neurology
51: 325-326
[Full Text]
Hamann, G. F., Schatzer-Klotz, D., Frohlig, G., Strittmatter, M., Jost, V., Berg, G., Stopp, M., Schimrigk, K., Schieffer, H.
(1998). Femoral injection of echo contrast medium may increase the sensitivity of testing for a patent foramen ovale. Neurology
50: 1423-1428
[Abstract][Full Text]
Garea, M. J., Aparicio-Blanco, M., Espino, P., Duenas, A., Dominguez, L. A., Bachiller, P.
(1998). Syndrome of continuous muscle fiber activity in a human immunodeficiency virus-infected patient. Neurology
50: 1506-1507
[Full Text]
Fry, J. M.
(1998). Treatment modalities for narcolepsy. Neurology
50: S43-S48
[Abstract][Full Text]
Heitner, J., Dickson, D.
(1997). Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects: A retrospective postmortem immunocytochemical and histofluorescent study. Neurology
49: 1306-1311
[Abstract][Full Text]
Saiz, A., Arpa, J., Sagasta, A., Casamitjana, R., Zarranz, J. J., Tolosa, E., Graus, F.
(1997). Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity. Neurology
49: 1026-1030
[Abstract][Full Text]
Piven, J., Saliba, K., Bailey, J., Arndt, S.
(1997). An MRI study of autism: The cerebellum revisited. Neurology
49: 546-551
[Abstract][Full Text]
Kumar, R., Maraganore, D. M., Ahlskog, J. E., Rodriguez, M.
(1997). Treatment of putative immune-mediated and idiopathic cervical dystonia with intravenous methylprednisolone. Neurology
48: 732-735
[Abstract][Full Text]
Murphy, E. L., Fridey, J., Smith, J. W., Engstrom, J., Sacher, R. A., Miller, K., Gibble, J., Stevens, J., Thomson, R., Hansma, D., Kaplan, J., Khabbaz, R., Nemo, G.
(1997). HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. Neurology
48: 315-320
[Abstract][Full Text]
(1997). A Prospective, Quantitative Study of the Natural History of Facioscapulohumeral Muscular Dystrophy (FSHD): Implications for Therapeutic Trials. Neurology
48: 38-46
[Abstract][Full Text]
Gilbert, G. J.
(1997). Cobalamine Deficiency. Neurology
48: 295-295
[Full Text]
Berger, J. R.
(1997). Cobalamine Deficiency. Neurology
48: 295-295
[Full Text]
Chatterjee, A., Yapundich, R., Palmer, C. A., Marson, D. C., Mitchell, G. W.
(1997). Reply from the Authors: Cobalamine Deficiency. Neurology
48: 295-295
[Full Text]
Paddock-Eliasziw, L. M., Eliasziw, M., Barr, H. W.K., Barnett, H. J.M.
(1996). Long-term prognosis and the effect of carotid endarterectomy in patients with recurrent ipsilateral ischemic events. Neurology
47: 1158-1162
[Abstract][Full Text]
Devuyst, G., Bogousslavsky, J., Ruchat, P., Jeanrenaud, X., Despland, P.-A., Regli, F., Aebischer, N., Karpuz, H. M., Castillo, V., Guffi, M., Sadeghi, H.
(1996). Prognosis after stroke followed by surgical closure of patent foramen ovale: A prospective follow-up study with brain MRI and simultaneous transesophageal and transcranial Doppler ultrasound. Neurology
47: 1162-1166
[Abstract][Full Text]
(1996). Neutralizing antibodies during treatment of multiple sclerosis with interferon beta-1b: Experience during the first three years. Neurology
47: 889-894
[Abstract][Full Text]
Bogousslavsky, J., Garazi, S., Jeanrenaud, X., Aebischer, N., Van Melle, G., For the Lausanne Stroke with Paradoxal Embolism St,
(1996). Stroke recurrence in patients with patent foramen ovale: The Lausanne Study. Neurology
46: 1301-1301
[Abstract][Full Text]
Uyama, E., Nohira, O., Chateau, D., Tokunaga, M., Uchino, M., Okabe, T., Ando, M., Tome, F.M.S.
(1996). Oculopharyngeal muscular dystrophy in two unrelated Japanese families. Neurology
46: 773-778
[Full Text]
Connolly, A. M., Pestronk, A., Planer, G. J., Yue, J., Mehta, S. B., Choksi, R.
(1996). Congenital muscular dystrophy syndromes distinguished by alkaline and acid phosphatase, merosin, and dystrophin staining. Neurology
46: 810-814
[Full Text]
North, K. N., Miller, G., Iannaccone, S. T., Clemens, P. R., Chad, D. A., Bella, I., Smith, T. W., Beggs, A.H, Specht, L. A.
(1996). Cognitive dysfunction as the major presenting feature of Becker's muscular dystrophy. Neurology
46: 461-464
[Abstract][Full Text]
Chamorro, A., Vila, N., Saiz, A., Alday, M., Tolosa, E.
(1996). Reply from the Author: Safety of heparin in acute ischemic stroke. Neurology
46: 589-591
[Full Text]
Pegoraro, E., Schimke, R. N., Garcia, C., Stern, H., Cadaldini, M., Angelini, C., Barbosa, E., Carroll, J., Marks, W. A., Neville, H. E., Marks, H., Appleton, S., Toriello, H., Wessel, H. B., Donnelly, J., Bernes, S. M., Taber, J. W., Weiss, L., Hoffman, E. P.
(1995). Genetic and biochemical normalization in female carriers of Duchenne muscular dystrophy: Evidence for failure of dystrophin production in dystrophin-competent myonuclei. Neurology
45: 677-690
[Abstract][Full Text]
Leao, M.
(1995). Valproate as a Cause of Hyperammonemia in Heterozygotes With ornithine-transcarbamylase Deficiency. Neurology
45: 593-594
[Full Text]
Clarfield, A. M., Friedland, R. P., Hedera, P.
(1995). Reversible Dementia. Neurology
45: 601-601
[Full Text]
Ermann, D.
(1988). Hospital Utilization Review: Past Experience, Future Directions. Journal of Health Politics, Policy and Law
13: 683-704
[Abstract]
